Press release
Longevity Formulas Publishes Independent Lab Test Results for NAD+ Supplements to Boost Transparency and Consumer Trust
Longevity Formulas, a UK-based supplement brand, has announced the public release of independent laboratory certificates of analysis (CoAs) for every batch of its NAD+ supplement range, setting a new benchmark for transparency, safety, and consumer confidence in the supplement industry.Each certificate, verified by BRCGS-certificated laboratories, confirms product composition, ingredient purity, and safety test results. The company is making these documents publicly accessible on its website before purchase, enabling customers to independently verify product specifications and ensuring full accountability across its supply chain.
"Supplement buyers deserve proof of what's inside the products they consume," said Mathew Stuckey, founder of Longevity Formulas. "By publishing batch-specific certificates of analysis, we're giving consumers independent verification of our ingredients and safety standards - something that should become standard practice in the entire supplement industry."
The certificates provide comprehensive details, including verification of active ingredient identity and purity, full excipient composition and quantities, capsule weight and dissolution rates, safety test outcomes, batch numbers, manufacturing dates, best-before dates, and official laboratory certifications. This open-access initiative directly responds to rising consumer concerns about label accuracy and supplement authenticity in the UK and global markets.
The NAD+ supplement range from Longevity Formulas includes NMN formulations and combination products produced in UK GMP-certified facilities. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme crucial for cellular energy production, DNA repair, and overall vitality, but levels naturally decline with age. Independent testing is conducted by certified laboratories to ensure that every product batch meets pharmaceutical-grade standards.
Recent investigations across the supplement industry have revealed significant inconsistencies in product purity, with some formulations containing less active ingredients than claimed on labels.
By releasing verified laboratory reports, Longevity Formulas aims to restore consumer trust and raise the bar for transparency in the UK supplement sector.
According to Grand View Research, the UK dietary supplements market is projected to reach £9.6 billion by 2033, growing at an 8.1% annual rate. NAD+ boosters represent one of the fastest-growing categories within this market, driven by the global trend toward longevity and cellular health. Publishing certificates of analysis for every production batch represents a major operational commitment and reflects pharmaceutical-grade integrity in supplement manufacturing.
All current batch certificates are available for public viewing at https://longevityformulas.co.uk/pages/nmn-certificate-of-analysis
The full NAD+ supplement collection can be explored at https://longevityformulas.co.uk/collections/nad-boosting-supplements
Contact Information
Founder: Matthew Stuckey
X(Twitter): @longevityUK
Linkedln: /company/longevityformulas
Website ~: https://longevityformulas.co.uk
Email: contact@longevityformulas.co.uk
Facebook: https://www.facebook.com/profile.php?id=61574040389643
Instagram: https://www.instagram.com/longevityformulas/
YouTube: https://youtube.com/@longevityformulas
TikTok: https://www.tiktok.com/@longevityformulas
Address: 85 Great Portland Street, First Floor, London, W1W7LT
About Longevity Formulas
Longevity Formulas is dedicated to advancing healthy aging and cellular vitality through clinically tested formulations. The company's NAD+ and NMN-based supplements are designed to support natural energy metabolism, DNA repair, and overall wellness - helping individuals maintain optimal cellular function at every stage of life.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Longevity Formulas Publishes Independent Lab Test Results for NAD+ Supplements to Boost Transparency and Consumer Trust here
News-ID: 4259684 • Views: …
More Releases for NAD+
Test NAD+ at Home: CELFULL Launches Science-Backed Aging Tracker
Coral Springs, FL - Aug 20, 2025 - At the end of 2020, CELFULL launched the Hebe Youth Project, the world's first large-scale, real-world NAD+ supplementation study. The initiative aims to establish accurate baseline NAD+ values, assess aging levels, explore optimal supplementation strategies, and quantify the relationship between NAD+ and aging.
Image: https://www.globalnewslines.com/uploads/2025/08/4367a5b1043ece7e6611155ff767e121.jpg
BRET sensor correlation, analyte colors, and molecular interaction.
Over five years, CELFULL has collected more than 100,000 samples, establishing precise…
Nicotinamide Adenine Dinucleotide (NAD) Industry Outlook | Growth Opportunities …
Market Size and Growth
✦ The market was valued at approximately, reflecting strong, sustained growth. at a CAGR of 11.25 % during the forecast period (2024-2031)
✦ The driving force behind this expansion is a combination of surging global demand, technological advancements, and significant investments in new infrastructure projects.
Mergers and acquisition
ChromaDex rebranded as Niagen Bioscience in March 2025 to emphasize its focus on NAD+ science and its flagship ingredient, Niagen.
In early…
NAD-based Anti-Aging Market Surges as Next-Gen Liposomal NMN and NAD Nasal Spray …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Type (Supplements (Oral NAD Dietary Supplements, Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Convenience Stores, Pharmacies/Clinics, Online Stores)…
NAD in Georgia Launches Exclusive BR+NAD Outpatient Treatment Offer
NAD in Georgia introduces BR+NAD, an innovative 10-day outpatient treatment for addiction with a 90% effectiveness rate. Unlike traditional inpatient programs, it offers faster recovery, minimal side effects, and reduced costs ($12,500 vs. $27,000+). This holistic therapy, including NAD+ treatment, supports detox, cravings reduction, and brain health restoration, providing a sustainable, cost-effective solution for long-term recovery.
Alpharetta, GA - May 14, 2025 - NAD in Georgia proudly unveils its BR+NAD outpatient…
NAD+ Enhancer Market: An Extensive Analysis Predicts Significant Future Growth
NAD+ Enhancer Market Overview :
The NAD+ Enhancer Market is significant growth determined by increasing consumer awareness of cellular health, aging-related research, and longevity-focused nutraceuticals. NAD+ (Nicotinamide Adenine Dinucleotide) plays a crucial role in cellular metabolism and energy production, making NAD+ enhancers highly sought after in anti-aging, cognitive health, and sports performance supplements. Advancements in biotechnology and clinical studies supporting NAD+ restoration's benefits have further fueled market expansion. Key players are…
NAD Electronics Introduces the C 379 HybridDigital DAC Amplifier
The new addition to the Classic Series combines innovation and value to deliver refined performance and sound quality.
MAY 2, 2024 - MUNICH, GERMANY - NAD Electronics, a leading manufacturer in high-performance audio, today announces the launch of its new Classic Series amplifier, the C 379 HybridDigital DAC Amplifier at the HIGH END Munich International Audio Show. The C 379 builds on NAD's commitment to innovation and value-driven performance with a…
